Home Tags PBMs
Dispensed: Pharma middlemen get their day in the hot seat, life at Flatiron Health a year after acquisition, and almost $1 billion invested in clinica...
Welcome to Dispensed, Business Insider's weekly newsletter giving you a dose of pharma, biotech, and healthcare news.
Congress grilled little-known middlemen over the high cost of prescription drugs. Here’s how they defended themselves.
Pharmacy benefit managers are defending the tactics they use to keep prescription drug costs down and pointing the finger back at Big Pharma.
These powerful but little-known companies that have been blamed for high drug prices are now coming out of the shadows for a congressional interrogati...
The US has a high drug prices problem. These obscure but powerful companies will now face some tough questions on Capitol Hill.
The CEO of a $210 billion pharma company says that US drug prices are working against patients. One chart explains why.
The CEO of the French drugmaker Sanofi provided an unusual look behind the curtain of US drug prices.
The CEO of Merck has an ominous warning for the middlemen who stand between drug makers and patients
Merck CEO Kenneth Frazier thinks something has to change within the pharmaceutical industry to fix the issue of drug pricing. "I don't understand where we live in a world where 50% of the value goes to supply chain," Frazier said at an event at the Economic Club of New York.
CARL ICAHN: The $67 billion Cigna-Express Scripts merger may ‘rival the worst acquisitions in corporate history’
The billionaire investor Carl Icahn is not a fan of Cigna's plan to purchase the pharmacy benefit manager Express Scripts, a $67 billion deal that was announced in March. In a letter to Cigna stockholders sent Tuesday, Icahn said the deal "may well rival the worst acquisitions in corporate history."
How a city in Illinois decided to sue to combat high drug prices after realizing it was spending $500,000 on one drug
A recent "60 Minutes" episode highlighted a lawsuit between Rockford Illinois, and a drugmaker over the rising cost of prescription drugs that led to the city spending half a million dollars treating two babies.
‘There’s other s— in the vial’: Bombshell lawsuit claims no one knows exactly what’s in a drug that’s cost the gov...
OPINION: The government has spent over a billion on a drug called Acthar and allegedly no one at the company even knows what it's actually made of.
Mom-and-pop pharmacies on the verge of going out of business blame CVS. They've rallied lawmakers — both Democrats and Republicans — to help.
OPINION: Neither CVS nor Express Scripts should get to make any moves before we know what's really going on inside the business of a pharmacy benefit manager.